APTEVO THERAPEUTICS INC
APVO · NASDAQ
Updated at 2026-10-14 09:34:49
- Today's High
- $1.79
- Today’s Low
- $1.70
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.79
- Previous Close
- $1.83
- Volume
- 286.36K
- Market Cap
- $3.32M
- P/E Ratio
- --
- EPS
- $-51.31
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 2401 4TH AVENUE, SEATTLE, WA, UNITED STATES, 98121
- Country
- US
- Listing Date
- 2016-07-20
- Fiscal Year End
- December
- Shares Outstanding
- 1.25M
- CIK
- 0001671584
- Website
- aptevotherapeutics.com
Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company is headquartered in Seattle, Washington.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
-$220K
2025-09-30
$0
Operating Expenses
2026-06-30
$6.44M
2026-03-31
$6.8M
2025-12-31
$5.91M
2025-09-30
$7.61M
Net Income
2026-06-30
-$6.35M
2026-03-31
-$6.69M
2025-12-31
-$5.8M
2025-09-30
-$7.54M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
2.63K%
2025-09-30
--
Earnings Per Share
2026-06-30
$-5.31
2026-03-31
$-6.41
2025-12-31
$-5.91
2025-09-30
$-40.14
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$6.49M
2026-03-31
-$6.66M
2025-12-31
-$5.72M
2025-09-30
-$7.5M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | -$220K | $0 |
| Operating Expenses | $6.44M | $6.8M | $5.91M | $7.61M |
| Net Income | -$6.35M | -$6.69M | -$5.8M | -$7.54M |
| Net Profit Margin | -- | -- | 2.63K% | -- |
| Earnings Per Share | $-5.31 | $-6.41 | $-5.91 | $-40.14 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$6.49M | -$6.66M | -$5.72M | -$7.5M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.